OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Check Point Software Technologies.../  IL0010824113  /

IEX
5/10/2024  9:59:51 PM Chg. -0.85 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
151.57USD -0.55% 34,196
Turnover: 5.2 mill.		 -Bid Size: - -Ask Size: - 17.72 bill.USD - 21.08
GlobeNewswire 1:15 AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counse...
GlobeNewswire 5/10 Checkpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire 5/9 PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurre...
Newsfile Corp 5/9 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investors to Secure ...
GlobeNewswire 5/9 Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sag...
GlobeNewswire 5/9 ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/9 Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 5/9 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire 5/8 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire 5/8 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
GlobeNewswire 5/8 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hir...
GlobeNewswire 5/7 INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. ...
GlobeNewswire 5/7 ALX Oncology Appoints Allison Dillon as Chief Business Officer
GlobeNewswire 5/7 ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Secure Couns...
GlobeNewswire 5/6 DEADLINE ALERT for IRBT, HRT, and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class ...
GlobeNewswire 5/6 ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024
GlobeNewswire 5/6 DEADLINE ALERT for HRT, CKPT, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class ...
GlobeNewswire 5/6 CKPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Checkpoint Therapeutics, Inc. ...
GlobeNewswire 5/6 Rising Cloud Threats Demand Advanced Defenses: Check Point's 2024 Report Highlights Urgent Need for ...
GlobeNewswire 5/6 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
Newsfile Corp 5/3 TOP RANKED ROSEN LAW FIRM Encourages Checkpoint Therapeutics, Inc. Investors to Secure Counsel Befor...
GlobeNewswire 5/3 PDS Biotechnology Announces Details of Virtual KOL Event
GlobeNewswire 5/3 Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/3 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire 5/2 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkp...